CSS Industries Inc. (NYSE:CSS) shares moved up 4.53% in last trading session and ended the day at $26.28. CSS Gross Margin is 32.40% and its has a return on assets of 5.30%. CSS Industries Inc. (NYSE:CSS) quarterly performance is -3.49%.
CSS Industries Inc. (NYSE:CSS) on Monday reported fiscal third-quarter profit of $9.7 million. The Philadelphia-based company said it had profit of $1.06 per share. The maker of gift wrap, gift bags and greeting cards posted revenue of $104.6 million in the period.
TD Ameritrade Holding Corporation (NASDAQ:AMTD) ended the last trading day at $28.81. Company weekly volatility is calculated as 3.84% and price to cash ratio as 7.82. TD Ameritrade Holding Corporation (NASDAQ:AMTD) showed a weekly performance of -0.41%.
TD Ameritrade Holding Corporation (NASDAQ: AMTD) announced that it will hold its annual meeting of stockholders on Thursday, Feb. 18, 2016. The meeting will begin at 9:00 a.m. CST and will take place at the Company’s corporate headquarters, located at 200 South 108th Avenue in Omaha, Neb.
On 26 January, BioAmber Inc. (NYSE:BIOA) shares fell -0.96% and was closed at $4.14. BIOA EPS growth in last 5 year was 3.30%. BioAmber Inc. (NYSE:BIOA) year to date (YTD) performance is -33.01%.
On 14 January, BioAmber Inc. (NYSE:BIOA), announced that it has commenced an underwritten public offering of its common stock. In addition, BioAmber expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares fell -1.23% in last trading session and ended the day at $152.64. ALXN Gross Margin is 91.00% and its has a return on assets of 2.60%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) quarterly performance is -10.82%.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2015 on Wednesday, February 3, 2016 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast on Wednesday, February 3, 2016, at 10:00 a.m. Eastern Time (ET).
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) caters to the Healthcare space. It has a net profit margin of -74.50% and weekly performance is 4.29%. On the last day of trading company shares ended up at $7.29.
Zacks Investment Research upgraded shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) from a sell rating to a hold rating in a research note released on Thursday morning, AnalystRatings.NET reports.
Leave a Reply